Key Highlights

  • The fund tracks U.S. healthcare companies, including pharmaceutical, biotechnology and equipment firms.
  • Eli Lilly, Johnson & Johnson and AbbVie are the largest positions by market value.
  • The portfolio holds 100 companies, with a 0.37 percent expense ratio.
  • Net Assets were about $4.8 billion on November 11, 2026.

The iShares U.S. Healthcare ETF (NYSEARCA:IYH) closed at $79.20 on November 11, 2026, with net assets of about $4.8 billion. The fund seeks to track an index composed of U.S. equities in the healthcare sector, providing access to pharmaceutical, biotechnology and healthcare equipment companies. Its portfolio is oriented toward American drugmakers and health insurers, with a structure shaped by the largest companies in the sector.

Ticker and exchange

IYH, NYSE Arca

Benchmark index

Russell 1000 Health Care RIC 22.5/45 Capped Index

Net asset value

$79.17 (Nov 11, 2026)

Daily NAV change

Up $0.07 (0.09%)

Net assets

$4,833,226,556

Number of holdings

100

Expense ratio

0.37%

30-day SEC yield

1.03%

Distribution frequency

Quarterly

Fund inception

June 12, 2000

Index Design and Sector Focus

The index behind IYH is based on large U.S. healthcare companies and applies capping rules to limit the weight of the largest names. The rules keep any one company from dominating the portfolio, although the biggest drugmakers still carry substantial influence.

The 100 holdings cover drugmakers, biotechnology firms, health insurers, medical equipment producers and healthcare service providers. That mix means the fund is affected by both Drug Development news and policy decisions on insurance and reimbursement.

Leading Positions

Eli Lilly accounts for about 16.31 percent of market value, followed by Johnson & Johnson at 9.65 percent and AbbVie at 7.42 percent. Merck holds roughly 5.23 percent, and UnitedHealth Group accounts for about 5.22 percent. Thermo Fisher Scientific, Amgen, Gilead Sciences, Abbott Laboratories and Pfizer also appear among the top ten.

Eli Lilly is the largest single position in the fund, and the top two holdings together represent more than a quarter of the portfolio.

Trading and Distribution Details

About 298,844 shares traded on November 11, 2026, compared with a 30-day Average Daily Volume of roughly 1.14 million shares. The 30-day median bid-ask spread was 0.03 percent, and the fund had 61.05 million shares outstanding.

The fund distributes income quarterly, and the September 2026 payment totaled $0.190827 per share. The 30-day SEC Yield was 1.03 percent and the 12-month trailing yield was also 1.03 percent, both calculated at the end of October 2026.

Final Word

IYH offers a U.S.-focused view of healthcare, built around large drugmakers, biotechnology firms and insurers. Its 0.37 percent expense ratio and quarterly distributions shape the fund's terms. Future results will depend on drug pipelines, insurance policy and the broader spending trends in American healthcare.